Background-Continuous angiotensin-II infusion induced the uptake of monocytic fibroblast precursors that initiated the development of cardiac fibrosis; these cells and concurrent fibrosis were absent in mice lacking tumor necrosis factor receptor 1 (TNFR1). We now investigated their cellular origin and temporal uptake and the involvement of TNFR1 in monocyte-to-fibroblast differentiation. Methods and Results-Within a day, angiotensin-II induced a proinflammatory environment characterized by production of inflammatory chemokines, cytokines, and T H 1-interleukins and uptake of bone marrow-derived M1 cells. After a week, the cardiac environment changed to profibrotic with growth factor and T H 2-interleukin synthesis, uptake of bone marrow-derived M2 cells, and the presence of M2-related fibroblasts. TNFR1 signaling was not necessary for early M1 uptake, but its absence diminished the amount of M2 cells. TNFR1-knockout hearts also showed reduced levels of cytokine expression, but not of T H -related lymphokines. Reconstitution of wild-type bone marrow into TNFR1-knockout mice was sufficient to restore M2 uptake, upregulation of proinflammatory and profibrotic genes, and development of fibrosis in response to angiotensin-II. We also developed an in vitro mouse monocyte-to-fibroblast maturation assay that confirmed the essential role of TNFR1 in the sequential progression of monocyte activation and fibroblast formation. Conclusions-Development of cardiac fibrosis in response to angiotensin-II was mediated by myeloid precursors and consisted of 2 stages. A primary M1 inflammatory response was followed by a subsequent M2 fibrotic response. Although the first phase seemed to be independent of TNFR1 signaling, the later phase (and development of fibrosis) was abrogated by deletion of TNFR1. (Circ Heart Fail. 2015;8:352-361.
T he development of cardiac interstitial fibrosis and concurrent development of ventricular remodeling in the absence of myocyte death is frequently associated with inflammatory reactions.
1,2 Several inflammatory and fibrotic factors have been implicated in adverse cardiac remodeling, such as angiotensin-II (Ang-II) and tumor necrosis factor (TNF). [3] [4] [5] Although the literature suggests synergistic actions of Ang-II and TNF, [6] [7] [8] [9] the cellular and molecular mechanisms for their interactions are still unclear.
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In our previous work, we demonstrated that Ang-II exposure resulted in the immediate upregulation of monocyte chemoattractant protein-1 (MCP-1) in endothelial cells around small vessels, which attracted the influx of a distinct population of monocytic CD34 + CD45
+ fibroblast precursor cells into the myocardium. 10 Once the transient MCP-1 signal decreased, the monocytic precursors disappeared as well. In mice deficient in MCP-1, Ang-II did not induce the appearance of this fibroblast population, nor did these mice develop cardiac fibrosis in response to Ang-II stimulation, indicating that the development of interstitial fibrosis was initiated by the MCP-1-driven uptake of monocytic fibroblast precursors. 10 We observed similar mechanisms in a chronic ischemia/reperfusion cardiomyopathy model (no infarct), in which upregulation of MCP-1 was also necessary for the uptake of bone marrow-derived fibroblast precursors and concurrent development of fibrosis. 11 Exposure of wild-type (WT) mice to Ang-II resulted in increased levels of myocardial TNF, which were absent in Ang-II-challenged MCP1-knockout (KO) mice. 10 In subsequent studies, we found that mice with genetic deletion of TNF receptor 1 (TNFR1) were resistant to Ang-II-induced cardiac fibrosis and presented lesser cardiac hypertrophy and better cardiac function than WT mice.
Parallel to our in vivo work, we developed an in vitro assay of human monocyte-to-fibroblast maturation to replicate the in vivo events with respect to monocyte migration and differentiation. 13, 14 Using this transendothelial migration assay, we recapitulated our in vivo observations: using mononuclear cells we demonstrated that endothelial transmigration in response to MCP-1 was necessary for monocytes to mature into fibroblasts. 13 In addition, we showed that both Ang-II and TNF had to be present, as one or the other by itself did not increase the formation of fibroblasts from monocytes. 12 In the current study, we defined the temporal sequence of the cellular and molecular events involved in Ang-II-mediated cardiac fibrosis. We found that early infiltrating bone marrowderived monocytes polarized to classically activated M1 cells creating a proinflammatory environment, including the production of TNF. Within a few days, this response changed into a profibrotic milieu: there was an uptake and differentiation of alternatively activated M2 cells that further developed into myeloid-derived fibroblasts, whereas M1 markers largely disappeared. In vitro, we newly developed a model using mouse monocytes from WT and TNFR1-KO mice and mouse endothelial cells to investigate the role of TNFR1 in mouse monocyte-to-fibroblast maturation.
Together, we found that signaling through TNFR1 was necessary for monocyte-to-fibroblast formation. Our data suggest that the production of TNF by proinflammatory cells supported a TNFR1-mediated maturation process in profibrotic M2 cells, and thus serves as a mechanistic link between Ang-II-induced cardiac inflammation and fibrosis.
Methods
For expanded Methods, see Data Supplement.
Animals
Male and female C57BL/6-Tnfrsf1a tm1Imx /J (TNFR1-KO) and C57BL/6J (WT) mice (8 to 10 weeks) were infused with 1.5 μg/kg per minute Ang-II via subcutaneously implanted osmotic pumps; control animals received saline. 10, 12 Donor bone marrow was isolated from femur/tibias; recipient mice were irradiated with 100 Gy and received ≈10 6 cells via tail-vein injection. After 6 to 7 weeks, animals received Ang-II. All mice were euthanized with 2% isofluorane followed by cervical dislocation. The investigations conformed to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health. All animals were treated in accordance with the guidelines of the Baylor College of Medicine Animal Care and Research Advisory Committee.
Flow Cytometry
Hearts were excised and cells isolated by enzymatic digestion using 0.1 mg/mL Liberase TH Research Grade. [10] [11] [12] Cells were incubated with calcein AM (green-fluorescent after metabolization) together with directly conjugated or biotin-conjugated external antibodies followed by phycoerythrin-or phycoerythrin/Cyanine-5-conjugated secondary antibodies. In separate setups, cells were externally stained, permeabilized, and then incubated with internal antibodies. Fluorescein isothiocyanate/phycoerythrin/Cyanine-5 fluorescence intensities were measured on an Epics XL-MCL or a Cell Lab Quanta SC with companion softwares (gating strategies are shown in Figure IA and IB in the Data Supplement using FlowJo X 10.0.7).
Tissue Staining
Hearts were arrested in diastole, perfusion-fixed in Zinc-Tris buffer, and paraffin embedded. [10] [11] [12] (1) Rehydrated, permeabilized sections close to the midpapillary level were stained with antibodies. Slides were mounted using Fluoroshield with 4′,6-diamidino-2-phenylindole and analyzed on an Olympus AX70 upright microscope. Monochrome images for each fluorescence channel were acquired using QCapture Pro 6.0; composite images were created using Image J (v1.46r, National Institutes of Health). (2) Rehydrated sections were stained in 0.05% picrosirius red and mounted in Cytoseal XYL. Bright-field images were captured on an Olympus CKX41 inverted microscope using QCapture Pro 5.0. Quantitative analysis of collagen-stained areas was calculated using Image Pro Plus 5.1 to obtain percentages of the total myocardial area.
Quantitative Polymerase Chain Reaction
RNA was isolated using Trizol-reagent; cDNA was synthesized using Verso Reverse Transcription. A total of 1:10 dilutions of cDNA were run on a CX1000 Touch Thermal Cycler with a CFX96 Real-Time System using SsoAdvanced SYBR green mastermix (BioRad). All primers were validated according to the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines ( Table I in the Data Supplement). 15 Relative gene expression compared with control was calculated using the ΔΔCq method.
Mouse Transendothelial Migration Assay
Similar to reported protocols, 11, 12, 14 Mouse Cardiac Endothelial Cell Line from Cedarlane Labs (Burlington, NC) were seeded at 4×10 4 cells/ insert. Mouse monocytes (25×10 4 ; isolated from untreated mouse spleen using EasySep Mouse Monocyte Enrichment Kit) were added together with either saline or both Ang-II (1 ng/mL) and TNF (10 ng/mL) to the top well. Mouse MCP-1 (650 ng/mL) was added to the bottom well. After 4 days, adherent cells in the bottom well were stained with Giemsa and manually counted (see Refs. 12 and 14 for detailed cell identification); each setup was measured in triplicate. In separate setups, migrated cells were allowed to adhere on coverslips for immunostaining.
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Statistical Analysis
Kolmogorov-Smirnov tests were used to evaluate normal distribution and Bartlett tests to evaluate differences among SDs. Unpaired 2-tailed Student t tests (or Mann-Whitney if nonparametric) were used to compare differences between 2 groups. One-way ANOVA (or Kruskal-Wallis if nonparametric) was used to compare differences between >2 groups; Tukey-Kramer post hoc testing (or Dunn test if nonparametric) was performed when appropriate. A P value <0.05 was considered statistically significant (GraphPad InStat 3.06). Data in text and figures are expressed as mean±SEM, except for box plots.
Results
Infusion of Ang-II to WT Mice Induced the Immediate Presence of M1 Cells and Delayed Presence of M2 Cells
To study the temporal profile of Ang-II-induced uptake of infiltrating cells, we performed immunostaining on WT hearts. As shown in Figure 1A , at 1 day we found many CD86 + M1 cells, but only few at 7 days; these cells were negative for procollagen type I. By contrast, at 1 day, we found few M2 cells, but many M2 cells after 7 days that were also positive for procollagen type I (CD301 + , Figure 1B ; CD206 + , Figure 1C ). We obtained similar results using inducible NO synthase and arginase as additional M1/M2 markers ( Figure II in Figure 1D1 ) that decreased to 0.8±0.1% after 7 days. We obtained similar results using CD16/32 as an M1 marker ( Figure IIIA1 and IIIA2 in the Data Supplement). By contrast, at early times, we Figure 1F1 ). However, these numbers increased by 7 days to 4.8±0.3% and 5.0±0.5%, indicating a predominance of M2 cells after longer Ang-II infusion. Likewise, the number of CD301 + ( Figure 1E2 ) and CD206 + ( Figure 1F2 ) cells that also expressed collagen type I increased over time, as did M2 cells that were positive for α-smooth muscle actin (αSMA; Figure IV 
Infusion of Ang-II to TNFR1-KO Mice Induced the Immediate Presence of M1 Cells, But the Delayed Appearance of M2 Cells Was Absent
We found that the amount of CD86 + CD45
+ M1 cells in TNFR1-KO hearts was not different compared with WT levels at both 3-and 7-day Ang-II infusion (1.4±0.2% and 0.7±0.1%; Figure  1D1 ). However, the amounts of CD301 + CD45 + ( Figure 1E1 ) and CD206 + CD45
+ ( Figure 1F1 ) M2 cells were lower at 7 days (0.8±0.4% and 1.9±0.2%) than the corresponding levels in WT mice. Similarly, the numbers of collagen type I positive CD301 + ( Figure 1E2 ) and CD206 + ( Figure 1F2 ) M2 cells were also lower in TNFR1-KO than in WT hearts. We obtained similar results using CD16/32 and CD150 as M1/M2 markers ( Figure  III in the Data Supplement). These data indicated that TNFR1 signaling was not involved in the uptake of M1 cells, but lack of TNFR1 reduced the uptake or polarization of CD45 + monocytes into M2 cells in the Ang-II-challenged heart. Of note, the kinetics of Ang-II-induced cellular uptake in TNFR2-KO hearts did not differ from WT levels (Figure VI in the Data Supplement), supporting our previous results that TNFR2 was not involved in the Ang-II-induced cardiac fibrosis.
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Infusion of Ang-II to WT Mice Induced the Immediate Increase of Proinflammatory Factors and the Delayed Increase of Profibrotic Factors
We have previously described an upregulation of distinct inflammatory and fibrotic proteins in the WT heart after 7-day Ang-II infusion. 10, 12 We now extended these observations by evaluating expression levels at earlier time points (1 and 3 days) and including additional factors (interleukin [IL]-1β, interferon-γ, IL-4, and IL-13). We found that transcriptional activation of TNF was immediately upregulated and persisted until ≥7 days ( Figure 2A ). Other proinflammatory factors such as MCP-1, IL-1β, IL-6, and interferon-γ were also highly upregulated early ( Figure 2B-2E ), whereas anti-inflammatory . Statistics: *Statistically significant difference between saline-treated (WT, n=8; TNFR1-KO, n=3) and 3-day (WT, n=6; TNFR1-KO, n=5) or 7-day (WT, n=7; TNFR1-KO, n=5-7) Ang-II-infused mice and †between 3-and 7-day Ang-II-infused mice within the same genetic background (Kruskal-Wallis, Dunn). NS indicates not significant. and profibrotic factors, such as IL-4, IL-13, transforming growth factor-β1, and osteopontin, were maximally increased after 7 days ( Figure 2F-2I ).
Infusion of Ang-II to TNFR1-KO Mice Did Not Increase Levels of M1-or M2-Related Factors, But Increased T H 1-and T H 2-Related Factors
Similar to our earlier 7-day study, 12 in TNFR1-KO hearts, we found reduced expression levels of genes associated with inflammation (TNF, MCP-1, IL-1β, and IL-6; Figure 2A -2D) and fibrosis (transforming growth factor-β1, osteopontin; Figure 2H and 2I) compared with WT levels. However, synthesis of T H 1 (interferon-γ) and T H 2 (IL-4, IL-13) products were unaffected by deletion of TNFR1 ( Figure 2E-2G ). These data indicated that TNFR1 signaling was necessary for cytokine, chemokine, and growth factor activation, but not for lymphokine production. 
Ang-II-
Ang-II-Induced Fibroblast Precursors Were of Bone Marrow Origin and Their Uptake Depended on TNFR1 Signaling
We found that chimeric TNFR1-KO mice with WT-bone marrow mounted a similar fibrotic response as WT mice:
(1) As shown in Figure 4A1 and 4A2 and Figure IX in the Data Supplement, after 7 days, chimeric TNFR1-KO/WT mice developed cardiac fibrosis. Specifically, levels of collagen deposition in these hearts (5.7±0.6%) were comparable with those in WT hearts (5.2±1.0%) and significantly higher than in TNFR1-KO hearts (2.0±0.1%). (2) In chimeric TNFR1-KO/ WT mice, mRNA expression levels of collagen types I and III, TNF, IL-1β, and transforming growth factor-β1 ( Figure 4B ) were restored to WT levels and were significantly greater than in TNFR1-KO hearts. ( Figure 5A1 and 5B1), as well as increased numbers of CD34 + CD45 + precursors ( Figure 5C1 ); all 3 populations were also positive for collagen type I expression ( Figure 5A2 , 5B2, and 5C2). Taken together, these data confirm that infiltrating myeloid fibroblast precursor cells were of bone marrow origin and that TNFR1 was necessary for their uptake and maturation in the heart.
In Vitro, Mouse Monocyte-to-Fibroblast Maturation Depended on TNFR1 Signaling
Previously, we have exclusively used human mononuclear cells and antibody-mediated inhibition/activation. [12] [13] [14] 16 In the current study, we developed an assay using cells from genetically altered mice. We isolated mouse monocytes from untreated WT and TNFR1-KO mice and subjected them to migration through mouse endothelial cells in response to MCP-1. After 4 days, we found significantly more fibroblasts in the Ang-II/ TNF-stimulated WT cells than in the Ang-II/TNF-stimulated TNFR1-KO cells ( Figure 6A) ; the amount of fibroblasts in Ang-II/TNF-stimulated TNFR1-KO cells was not different than in the unstimulated TNFR1-KO or unstimulated WT setups. Furthermore, adherent WT cells after 4 to 6 days were spindle shaped and expressed CD206 and CD301, together with procollagen type I ( Figure 6B and 6C) , indicating their M2-related fibroblast phenotype. These cells also expressed TNFR1 (Figure 6D) . By contrast, adherent cells after 1 day were primarily round and positive for M1 markers CD86 and inducible NO synthase ( Figure 6E ), similar to our recent human in vitro reports.
14 These in vitro data expand our pervious observations indicating that TNFR1 signaling was necessary for the Ang-IIinduced monocyte-to-fibroblast maturation.
Discussion
This report extends our studies into the mechanism by which chemokine induction results in the rapid onset of interstitial cardiac fibrosis. Our laboratory has focused on 2 murine models of noninfarctive injury: an ischemic reperfusion cardiomyopathy 17 and an Ang-II infusion protocol, 10 both leading to cardiac hypertrophy, remodeling, and fibrosis. We found remarkably similar characteristics: (1) MCP-1 upregulation was prolonged (≥1 week). 10, 17 (2) Myeloid fibroblast precursor cells appeared in the heart. 10,11 (3) MCP-1 was required to attract this myeloid cell population, as these cells were absent in MCP-1-KO hearts.
10,18 (4) Myeloid fibroblasts were distinct in morphology and proliferation activity and expressed CD34, CD45, and C-C chemokine receptor type 2 (MCP-1 receptor), 10, 11, 19 distinguishing them from tissue-resident cells; they were also positive for typical fibroblast markers (collagen type I, αSMA, discoidin domain-containing receptor 2). [10] [11] [12] [13] 16 (5) By means of bone marrow transplantation experiments using either β-galactosidase-labeled cells (ischemia/reperfusion cardiomyopathy) 11 or cells lacking TNFR1 (Ang-II infusion; current study), we showed that this myeloid fibroblast population was of bone marrow origin, and its uptake required mechanisms involving TNFR1 signaling. (6) Cardiac fibrosis peaked within the first 2 weeks and persisted as long as the stimulus was administered 10, 17 ; however, the fibroblast precursor population disappeared as soon as MCP-1 induction diminished (after 1 week). Therefore, MCP-1 activation and appearance of CD34 + CD45
+ precursor cells were required for triggering the development of cardiac fibrosis, but other mechanisms drove maintenance and progression. The authors want to emphasize that this unique, chemokine-dependent mechanism of myeloid fibroblast generation does not account for all of the mechanisms by which fibroblasts may be generated as part of growth or in response to pathological stimuli, as discussed below.
Chemokine-Dependent Fibrosis
Our study targets an acute inflammatory/fibrotic response modulated by chemokine, cytokine, and T-lymphocyte products that results in the formation of myeloid fibroblasts, and the cellular signaling associated with its generation. We and others have demonstrated a similar chemokine-dependent inflammatory response associated with obstructive and Ang-II-generated renal disease and pulmonary fibrosis. [19] [20] [21] [22] We have also studied the role of chronic cardiac inflammation and fibrosis associated with aging. We observed the presence of CD45 + myeloid fibroblasts persisting and increasing with time in the aging mouse heart; their presence was associated with persistent and increasing MCP-1 induction that may account, at least in part, for the ongoing presence of myeloid fibroblasts. 23 In these aging studies, we also described another distinct class of fibroblasts arising from CD44 + CD45
− mesenchymal stem cells that differentiate normally into collagensecreting cells, but failed to express αSMA in response to transforming growth factor-β, which distinguished this cell population from the myeloid fibroblast population in the ischemia/reperfusion cardiomyopathy and Ang-II models. 24 
Origin of Myeloid Fibroblasts
We previously reported the uptake of monocytic CD34 + CD45 + fibroblast precursors in the Ang-II-exposed heart. 10, 12 We now expand these observations by performing bone marrow transplantation experiments for fibroblast lineage tracing. By irradiating TNFR1-KO mice and reconstituting their bone marrow with WT cells, we restored expression of TNFR1 in cells of the myeloid lineage. Using such chimeric TNFR1-KO/WT mice for Ang-II infusion, we found that, although TNFR1 was not present on resident cells, the presence of TNFR1 on bone marrow cells was sufficient to restore the development of Ang-II-induced cardiac fibrosis to the same extent as observed in WT hearts (Figures 4 and 5 ; Figures IX and X in the Data Supplement). Because many of the TNFR1 + cells in chimeric TNFR1-KO/WT mice were also positive for αSMA, we provide evidence that (1) fibroblast precursors were of bone marrow origin and (2) TNFR1 signaling was involved in their uptake or maturation into myofibroblasts.
Myeloid fibroblasts may also derive from endogenous macrophages. Recent studies describe tissue-resident macrophages arising from yolk-sac progenitors: In the central nervous system, monocyte-derived macrophages were shown to express CD45 high , whereas microglia-derived resident macrophages were CD45 low . 25 In our study, we found that most TNFR1 + cells in mouse heart after Ang-II infusion were CD45 high ( Figure  VII in the Data Supplement), suggesting that these cells are of monocyte origin rather than tissue-resident. In the heart, in response to Ang-II, a resident macrophage population of embryonic origin was shown to expand by proliferation in addition to uptake of monocyte-derived macrophages, but this resident population did not express C-C chemokine receptor type Figure IX in the Data Supplement) and quantitative analysis (A2) are shown. Chimeric TNFR1-KO/WT mice (n=7) developed interstitial cardiac fibrosis similar to WT/WT mice (n=5) and more than TNFR1-KO/TNFR1-KO mice (n=4). B, Transcriptional activation of selected genes. Chimeric TNFR1-KO/WT mice (n=9) showed increased mRNA levels of collagen types I and III, TNF, interleukin (IL)-1β, and transforming growth factor (TGF)-β1, similar to WT/WT levels (n=6) and higher than TNFR1-KO/TNFR1-KO levels (n=3). C, Perfusion-fixed tissue was stained for TNFR1 and α-smooth muscle actin (αSMA); representative images are shown (blue, nuclear 4′,6-diamidino-2-phenylindole; quantification: Figure X in the Data Supplement). Statistics: *Statistically significant difference between TNFR1-KO/TNFR1-KO and TNFR1-KO/WT groups (Kruskal-Wallis, Dunn). NS indicates not significant.
2 nor was it responsive to MCP-1. 26 In our study, the presence of fibroblast precursors was MCP-1 dependent, again suggesting that these cells rather arise from monocytes. Another report also described a critical role for resident macrophages in the steady-state heart; however, when homeostasis was perturbed by myocardial infarction, macrophages mostly derived from blood monocytes. 27 Another study using the platelet-derived growth factor alpha receptor for fate specification suggested a precursor that has selective multipotentiality for various mesenchymal cells that may include fibroblasts. 28 The role of different mesenchymal subpopulations in cardiac, perhaps more chronic, fibrosis represents an ongoing interest of our group as well. We do not rule out a participation of such resident precursors; however, the role of this population in the chemokine-dependent inflammatory fibrosis described here is unlikely.
Uptake of Myeloid Fibroblasts
Within 1 day of Ang-II infusion we observed the uptake of M1 cells in the heart, concurrent with increased synthesis of MCP-1, TNF, distinctive cytokines, and T H 1-related interleukins, altogether creating a proinflammatory environment (Figures 1-3; Figures II, III , VIII in the Data Supplement). Later, at 7-day Ang-II infusion, the number of M1 cells declined, while M2 cells emerged; these cells were not associated with TNF, but with collagen production (Figures 1 and 3; Figures II-IV, VIII in the Data Supplement). We also observed simultaneous synthesis of distinct profibrotic factors and T H 2-related interleukins (Figure 2 ). This sequential appearance of M1-and M2-related cells and products indicated that an initial, proinflammatory environment gradually transited into a later anti-inflammatory and profibrotic milieu.
At this point the authors cannot distinguish whether the observed M2 cells polarized from M1 cells or were generated from a separate monocytic subpopulation (or both), and this may be difficult to test in vivo. Based on in vitro observations, in which we eliminate early migrating M1 cells from the assay and still found increased numbers of later migrating M2 cells, 14 we hypothesize that in our model M2 cells mature from separate precursors instead of being generated by M1-to-M2-conversion. The existence of different precursor subpopulations may be supported by our observations of CD34 expression on cardiac fibroblast precursors ( Figure V in the Data Supplement). CD34 has been regarded as a primitive cell marker, but has gained interest because of its involvement in asymmetrical cell division of precursor cells, 29 and CD34 expression may be necessary for the ability of M2 to form a fibroblast. Because the appearance of CD34 + CD45
+ cells correlated with the appearance of M2 cells, and M2 cells, but not M1 cells, expressed CD34, we can speculate that CD34 was necessary for M2-to-fibroblast formation, or only those M2 cells that expressed CD34 polarized into fibroblasts. Together with our observations that systolic blood pressure was also lower in Ang-II-infused TNFR1-KO mice, 12 the contribution of vascular remodeling to the cellular uptake of different precursors may also be a decisive factor in guiding the migration and maturation of these subpopulations. Further experiments to investigate these hypotheses are currently ongoing.
Role of TNFR1
This article was designed to affirm the hypothesis of specific interactions of Ang-II and TNF and further pursue the mechanisms of that interaction. In mice with genetic deletion of TNFR1 we found little evidence for M2 generation in the Ang-II-exposed heart, whereas the amount of infiltrating M1 cells was not different than WT levels (Figure 1 ; Figure IIIA in the Data Supplement). The uninhibited influx of M1 cells in TNFR1-KO hearts indicated that the onset of inflammation was independent of TNFR1 signaling. However, signaling through TNFR1 played an important role in the transition to a fibrotic environment that favored fibroblast maturation and collagen deposition. Our initial studies demonstrated that MCP-1 deletion largely inhibited TNF induction and macrophage influx in response to Ang-II. 10 It is thus likely that TNF was a principal agent in M1 mediation of the cellular progression of fibrosis. From our data, TNF should now be considered as an additional influence on inflammation resolution leading to fibrosis, rather than being a strictly proinflammatory mediator. Future studies should investigate whether M1 inflammation is reduced by an autocrine response to its own TNF product, thus allowing M2 precursors to respond to T H 2 mediators IL-4 and IL-13, or whether M2-to-fibroblast differentiation is directly aided by TNF, or both. 
In Vitro Model of Monocyte-to-Fibroblast Maturation
Parallel to our in vivo studies, we developed an in vitro assay that allowed a more careful examination of quantitative, qualitative, and temporal aspects of monocyte migration and polarization that are not directly addressable in vivo. 13, 14 In this assay, we observed the maturation of human mononuclear cells into myeloid-derived fibroblasts after successful MCP-1-mediated migration through a human endothelial layer. We characterized the requirement of MCP-1-guided transendothelial migration, the inhibitory effects of serum amyloid P, the involvement of rho-associated, coiled-coil-containing protein kinase 1 (ROCK-1) signaling, and the requirement of IL-13 production for monocyte-to-fibroblast differentiation. 10, 13, 16, 23 Important for the current study, we demonstrated that neither Ang-II nor TNF alone was able to promote monocyte-to-fibroblast formation, but both agents had to be present at the same time. 12 We now developed a similar assay using mouse WT and TNFR1-KO monocytes and mouse endothelium. We were thus able to further characterize the temporal development of mouse fibroblast formation. Specifically, we show that also in vitro TNFR1 was necessary for Ang-II-stimulated monocyte-to-fibroblast Figure 6 ). Moreover, we have established a novel assay protocol that allows us to use cells from any genetically manipulated mice to test for specific factors involved in monocyte-to-fibroblast formation, and future studies using cells from diverse mouse strains are warranted.
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Conclusions
Ang-II-induced MCP-1 upregulation resulted in the sequential and timely regulated uptake of bone marrow cells and induction of proinflammatory and profibrotic factors that drove the maturation of myeloid precursors into fibroblasts. Specifically (Figure 7) , MCP-1 induced the uptake of monocytic precursors that polarized to cytokine-producing M1 cells that, together with T H 1-related factors, created a proinflammatory environment. At later times, infiltrating monocytes became M2 cells, which was influenced by concurrent production of T H 2-related proteins and generation of distinct profibrotic factors. This profibrotic milieu drove the maturation of an M2 subpopulation further to fibroblasts that produced and secreted collagen, leading to cardiac fibrosis and remodeling.
Importantly, our study suggests that TNF produced by M1 cells was necessary for mediating a TNFR1-dependent maturation of M2 cells into collagen-producing fibroblasts providing further evidence for an Ang-II/TNF synergy. A newly developed in vitro model of transendothelial migration of mouse WT and TNFR1-KO monocytes reproduced the signaling and temporal aspect of M2-to-fibroblast development. Thus, we provide evidence for a mechanistic link between Ang-II-induced inflammation and concurrent cardiac fibrosis.
